Massachusetts Healthcare Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Massachusetts Healthcare Journal.

Press releases published on August 6, 2026

Aug. 6, 2026

Cartesian Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

Aug. 6, 2026

Cullinan Therapeutics Provides Corporate Update and Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Aug. 6, 2026

Avalo Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business Updates

Indeterminate GlobeNewswire

Aug. 6, 2026

Sotera Health Delivers Strong Second-Quarter and First-Half 2026 Results and Raises FY 2026 Outlook

Indeterminate GlobeNewswire

Aug. 6, 2026

Harrow Acquires Global Rights to TYRVAYA®, the First and Only FDA-Approved Nasal Spray for Dry Eye Disease

Indeterminate GlobeNewswire

Aug. 6, 2026

Intellia Therapeutics Announces Second Quarter 2026 Financial Results and Business Updates

Indeterminate GlobeNewswire

Aug. 6, 2026

Verano Announces Upcoming Conference Participation

Indeterminate GlobeNewswire

Aug. 6, 2026

Tilray Brands Expands THC Beverage Innovation with the Launch of Mollo Lite Blackberry Lemon Seltzer Multi-Pack

Indeterminate GlobeNewswire

Aug. 6, 2026

Climb Bio Reports Second Quarter 2026 Financial Results and Provides Business Updates

Indeterminate GlobeNewswire

Aug. 6, 2026

Monte Rosa Therapeutics Announces Second Quarter 2026 Financial Results and Business Updates

Indeterminate GlobeNewswire

Aug. 6, 2026

Ligand Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Aug. 6, 2026

Generate Biomedicines Inc. Reports Second Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

Aug. 6, 2026

Roivant Reports Financial Results for the First Quarter Ended June 30, 2026, and Provides Business Update

Indeterminate GlobeNewswire

Aug. 6, 2026

Korro Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

Aug. 6, 2026

Immunovant Provides Corporate Updates and Reports Financial Results for the Quarter Ended June 30, 2026

Indeterminate GlobeNewswire

Aug. 6, 2026

Mangoceuticals’ Merger Partner, Nuclea Energy Inc., Signs MOU with New Mining Co. to Advance Behind-the-Meter Modular Reactor Deployment for High-Density Computing Infrastructure

Indeterminate GlobeNewswire

Aug. 6, 2026

Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officer

Indeterminate GlobeNewswire

Aug. 6, 2026

GH Research Reports Second Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

Aug. 6, 2026

Aclaris Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate and Clinical Update

Indeterminate GlobeNewswire

Aug. 6, 2026

Assessment of AAE-C1INH Disease Burden and Validation of Clinical Trial Endpoints Published in Frontiers in Immunology

Indeterminate GlobeNewswire